Purchases and Sales Made in Q3 2023 in Inozyme Pharma, Inc. (INZY)
This table provides information about the institutional ownership of Inozyme Pharma, Inc. (INZY) during Q3 2023. The information is specifically focused on institutions that hold shares of Inozyme Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-4.4K- 34.26% |
$18K - $30.8K
|
8.44K
$24.7K
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-7.21K- 21.48% |
$29.5K - $50.5K
|
26.4K
$77.3K
|
|
|
Nov 09, 2023
Q3 2023
|
Citigroup Inc
|
SELL
|
- |
-10.1K- 99.82% |
$41.2K - $70.4K
|
18
$52.7
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-11.6K- 7.96% |
$47.4K - $81.1K
|
134K
$393K
|
|
|
Nov 14, 2023
Q3 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-17.5K- 20.43% |
$71.5K - $122K
|
68.1K
$200K
|
|
|
Nov 09, 2023
Q3 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-23.8K- 28.55% |
$97.2K - $166K
|
59.4K
$174K
|
|
|
Nov 14, 2023
Q3 2023
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-24.9K- 21.37% |
$102K - $174K
|
91.7K
$269K
|
|
|
Nov 14, 2023
Q3 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-115K- 54.45% |
$470K - $804K
|
96.1K
$282K
|
|
|
Nov 14, 2023
Q3 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-206K- 85.46% |
$843K - $1.44M
|
35.1K
$103K
|
|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-309K- 85.17% |
$1.27M - $2.17M
|
53.9K
$158K
|